Corcept Therapeutics
CORT | NASDAQ
$80.98
-$0.14 (-0.17%)
Nov 2, 2026, 2:08 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 36.63 | 37.33 | 31.84 | 21.38 | 20.41 | 28.43 |
PEG Ratio | -1.24 | 1.15 | 4.32 | -10.37 | 3.76 | 2.33 |
PS Ratio | 4.75 | 7.71 | 6.97 | 5.40 | 6.26 | 8.53 |
PB Ratio | 5.58 | 7.65 | 6.64 | 4.32 | 6.09 | 5.77 |
P/FCF Ratio | 25.49 | 26.55 | 26.51 | 18.09 | 13.68 | 20.03 |
P/OCF Ratio | 25.45 | 26.26 | 26.48 | 18.03 | 13.64 | 19.87 |
OCF/S Ratio | 18.65 | 29.34 | 26.34 | 29.94 | 45.87 | 42.94 |
Debt / Equity Ratio | 0.01 | 0.01 | 0 | 0 | 0 | 0 |
Quick Ratio | 2.85 | 3.26 | 4.31 | 6.80 | 5.50 | 9.97 |
Current Ratio | 2.92 | 3.35 | 4.39 | 6.89 | 5.60 | 10.07 |
Asset Turnover | 0.91 | 0.80 | 0.78 | 0.69 | 0.86 | 0.62 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | 15.38% | 20.56% | 20.95% | 20.21% | 29.94% | 20.26% |
Return on Assets | 11.91% | 16.62% | 17.08% | 17.38% | 26.55% | 18.54% |
Return on Invested Capital | 6.67% | 17.09% | 17.68% | 19.20% | 29.74% | 19.62% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 98.30% | 98.39% | 98.66% | 98.66% | 98.56% | 98.42% |
Net Profit Margin | 13.09% | 20.70% | 22% | 25.24% | 30.74% | 29.96% |
Pretax Profit Margin | 8.73% | 23.92% | 25.82% | 28.91% | 34.16% | 37.19% |
Operating Profit Margin | 5.88% | 20.29% | 22.24% | 28.03% | 34.01% | 36.23% |
FCF Margin | 18.62% | 29.02% | 26.31% | 29.84% | 45.75% | 42.59% |
EBITDA Margin | 8.98% | 24.12% | 26.04% | 29.23% | 34.96% | 36.86% |
Add to Watchlist
Select watchlists to add or remove CORT